Prasugrel development : Claims and achievementsSEREBRUANY, Victor; SHALITO, Inna; KOPYLEVA, Olga et al.Thrombosis and haemostasis. 2009, Vol 101, Num 1, pp 14-22, issn 0340-6245, 9 p.Article

Platelet-leukocyte interactions in inflammation and atherothrombosisMAY, Andreas E; LANGER, Harald; SEIZER, Peter et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 2, pp 123-127, issn 0094-6176, 5 p.Article

L-Arginine and atherothrombosisLOSCALZO, Joseph.The Journal of nutrition. 2004, Vol 134, Num 10S, pp 2798S-2800S, issn 0022-3166Conference Paper

Platelets and endothelial cellsSIEGEL-AXEL, Dorothea I; GAWAZ, Meinrad.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 2, pp 128-135, issn 0094-6176, 8 p.Article

Atherothrombosis: A widespread disease with unpredictable and life-threatening consequencesVILES-GONZALEZ, Juan F; FUSTER, Valentin; BADIMON, Juan J et al.European heart journal. 2004, Vol 25, Num 14, pp 1197-1207, issn 0195-668X, 11 p.Article

Function and role of microparticles in various clinical settingsNOMURA, Shosaku; OZAKI, Yukio; IKEDA, Yasuo et al.Thrombosis research. 2008, Vol 123, Num 1, pp 8-23, issn 0049-3848, 16 p.Article

Differentiating haemostasis from thrombosis for therapeutic benefit : Platelets: basic mechanisms and translational implicationsMCFADYEN, James D; JACKSON, Shaun P.Thrombosis and haemostasis. 2013, Vol 110, Num 5, pp 859-867, issn 0340-6245, 9 p.Article

Atherothrombosis and the vessel wallSTEFFEL, Jan; LIISCHER, Thomas F.Dialogues in cardiovascular medicine. 2007, Vol 12, Num 4, pp 237-249, issn 1272-9949, 13 p.Article

Genetic and environmental determinants of fibrin structure and function: Relevance to clinical diseaseSCOTT, Eleanor M; ARIËNS, Robert A. S; GRANT, Peter J et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 9, pp 1558-1566, issn 1079-5642, 9 p.Article

The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest painBRÜGGER-ANDERSEN, Trygve; PÖNITZ, Volker; KONTNY, Frederic et al.Thrombosis and haemostasis. 2009, Vol 102, Num 3, pp 555-563, issn 0340-6245, 9 p.Article

From vulnerable plaque to atherothrombosisTHIM, T; HAGENSEN, M. K; BENTZON, J. F et al.Journal of internal medicine. 2008, Vol 263, Num 5, pp 506-516, issn 0954-6820, 11 p.Conference Paper

Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosisDUCROCQ, Gregory; WALLACE, Joshua S; GABRIEL STEG, Philippe et al.European heart journal. 2010, Vol 31, Num 10, pp 1257-1265, issn 0195-668X, 9 p.Article

C-reactive protein: a surrogate risk marker or mediator of atherothrombosis? Authors' replyBLAKE, Gavin J; RIDKER, Paul M; VERMA, Subodh et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2003, Vol 54, Num 5, pp R1250-R1252, issn 0363-6119, 1257 [4 p.]Article

Nitric oxide-releasing aspirin : Will it say NO to atherothrombosis?ANTONIADES, Charalambos; TOUSOULIS, Dimitris; STEFANADIS, Christodoulos et al.International journal of cardiology. 2007, Vol 118, Num 2, pp 170-172, issn 0167-5273, 3 p.Article

Venous Thromboembolism and Atherothrombosis: An Integrated ApproachPIAZZA, Gregory; GOLDHABER, Samuel Z.Circulation (New York, N.Y.). 2010, Vol 121, Num 19, pp 2146-2150, issn 0009-7322, 5 p.Article

Interaction of Platelets and Inflammatory Endothelium in the Development and Progression of Coronary Artery DiseaseLANGER, Harald F; BIGALKE, Boris; SEIZER, Peter et al.Seminars in thrombosis and hemostasis. 2010, Vol 36, Num 2, pp 131-138, issn 0094-6176, 8 p.Article

Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypesNEWBY, Andrew C; GEORGE, Sarah J; ISMAIL, Yasmin et al.Thrombosis and haemostasis. 2009, Vol 101, Num 6, pp 1006-1011, issn 0340-6245, 6 p.Conference Paper

Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndromeBECAREVIC, M; ANDREJEVIC, S; MILJIC, P et al.Clinical and experimental rheumatology (Testo stampato). 2007, Vol 25, Num 3, pp 361-366, issn 0392-856X, 6 p.Article

Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? : Arguments in favor : COX-2 inihibitors and the trombotic riskMUKHERJEE, Debabrata.Thrombosis and haemostasis. 2006, Vol 96, Num 4, pp 407-412, issn 0340-6245, 6 p.Article

Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-α in patients with coronary heart diseaseLOWE, Gordon D. O; ROBINSON, Simon D; DAWSON, Pamela et al.Clinical science (1979). 2006, Vol 110, Num 3, issn 0143-5221, 327-328,353-360 [10 p.]Article

Binding and internalization of C-reactive protein by fcgamma receptors on human aortic endothelial cells mediates biological effectsDEVARAJ, Sridevi; DU CLOS, Terry W; JIALAL, Ishwarlal et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 7, pp 1359-1363, issn 1079-5642, 5 p.Article

Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damageYAZICI, M; DEMIRCAN, S; DURNA, K et al.International journal of clinical practice (Esher). 2005, Vol 59, Num 2, pp 150-155, issn 1368-5031, 6 p.Article

In-hospital initiation of statin therapy in acute coronary syndromes : Maximizing the early and long-term benefitsFONAROW, Gregg C.Chest. 2005, Vol 128, Num 5, pp 3641-3651, issn 0012-3692, 11 p.Article

Platelet hyperactivity after statin treatment discontinuationPUCCETTI, Luca; PASQUI, Anna Laura; PASTORELLI, Marcello et al.Thrombosis and haemostasis. 2003, Vol 90, Num 3, pp 476-482, issn 0340-6245, 7 p.Article

Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in cultureSERRADELL, Mireia; DIAZ-RICART, Maribel; CASES, Aleix et al.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, Num 6, pp 1079-1085, issn 0931-0509, 7 p.Article